# Another Drug Shows Potential for Functional Cures in Chronic Hepatitis B

Source: [MedPageToday.com - medical news for physicians](https://www.medpagetoday.com/meetingcoverage/aasld/123809) · 2026-11-10 · Medicine
Page: https://themorning.science/story/another-drug-shows-potential-for-functional-cures-in-chronic-hepatitis-b-494703b372a7e8f3
Kind: research · Impact: medium

## In brief

- A phase II study reported reductions in hepatitis B surface antigen (HBsAg) with a novel small interfering RNA (siRNA) therapy.
- The study enrolled patients with chronic hepatitis B virus (HBV) infection.
- The findings were covered by MedPage Today from the AASLD meeting.

## Why it matters

HBsAg reduction is a key marker in efforts toward a functional cure for chronic hepatitis B, so this phase II result is relevant to clinicians and researchers working on HBV treatment.

## Coverage

- [Another Drug Shows Potential for Functional Cures in Chronic Hepatitis B](https://www.medpagetoday.com/meetingcoverage/aasld/123809) — MedPageToday.com - medical news for physicians, 2026-11-10

Tags: hepatitis b, sirna, antiviral therapy, clinical trial, liver disease

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science